BR100 Increased By (1.56%)
BR30 Increased By (1.52%)
KSE100 Increased By (1.35%)
KSE30 Increased By (1.43%)
AGHA 7.90 Increased By ▲ 0.15 (1.94%)
BECO 5.22 Increased By ▲ 0.03 (0.58%)
BML 58.88 Increased By ▲ 0.22 (0.38%)
BOP 34.38 Increased By ▲ 0.69 (2.05%)
CNERGY 10.88 Increased By ▲ 0.27 (2.54%)
CSIL 5.39 Increased By ▲ 0.09 (1.7%)
FCCL 54.70 Increased By ▲ 0.96 (1.79%)
FFL 16.83 Increased By ▲ 0.37 (2.25%)
FNEL 1.21 Decreased By ▼ -0.01 (-0.82%)
KEL 7.44 Increased By ▲ 0.16 (2.2%)
KOSM 5.71 Increased By ▲ 0.07 (1.24%)
LOTCHEM 30.00 Increased By ▲ 0.35 (1.18%)
MLCF 97.70 Increased By ▲ 1.34 (1.39%)
NBP 206.75 Increased By ▲ 3.22 (1.58%)
NCPL 58.21 Increased By ▲ 1.36 (2.39%)
NPL 69.20 Increased By ▲ 1.89 (2.81%)
OGDC 322.00 Increased By ▲ 3.78 (1.19%)
PACE 10.79 Increased By ▲ 0.16 (1.51%)
PAEL 42.81 Increased By ▲ 1.04 (2.49%)
PIBTL 17.21 Increased By ▲ 0.40 (2.38%)
PPL 224.12 Increased By ▲ 3.95 (1.79%)
PRL 52.65 Increased By ▲ 3.60 (7.34%)
PTC 71.00 Increased By ▲ 0.99 (1.41%)
SSGC 29.60 Increased By ▲ 0.46 (1.58%)
TBL 9.90 Increased By ▲ 0.13 (1.33%)
TELE 8.98 Increased By ▲ 0.16 (1.81%)
TPL 17.45 Increased By ▲ 0.28 (1.63%)
TPLP 12.95 Increased By ▲ 0.44 (3.52%)
TREET 22.93 Increased By ▲ 0.34 (1.51%)
TRG 60.69 Increased By ▲ 0.47 (0.78%)
Topic

clinical trials

4G Clinical raises over $230mn growth equity from Goldman Sachs

4G Clinical raises over $230mn growth equity from Goldman Sachs

Published 29 Jun, 2021 06:13pm
  • Neither one of us was going to go back and get a PhD in biochemistry and discover a molecule, but the way that we're intending to help is through technology, through our business practices, you know, removing bottlenecks in the clinical trial process.
China's Sinovac vaccine 67pc effective against symptomatic infection: Chile report

China's Sinovac vaccine 67pc effective against symptomatic infection: Chile report

Published 16 Apr, 2021 07:39pm
  • The vaccine was 85% effective in preventing hospitalizations and 80% effective in preventing deaths, the government said in a report prepared by the Chilean health ministry.
  • Chile's study examined CoronaVac's effectiveness among 10.5 million people, again looking both at people who had been vaccinated and those who had not.
Valneva's COVID-19 shot set for Phase Three trial this month

Valneva's COVID-19 shot set for Phase Three trial this month

Updated 06 Apr, 2021 07:29pm
  • The vaccine, Valneva said, was "generally safe and well tolerated across all dose groups tested, with no safety concerns identified by an independent Data Safety Monitoring Board".
  • "Based on the data assessed, the company has decided to advance the high dose into the phase 3 clinical trial. Other trials, including booster trials, involving antigen sparing doses will also be evaluated," Valneva said.
COVID-19: Govt's plan to procure vaccine is insufficient to protect country's 220 million population

COVID-19: Govt's plan to procure vaccine is insufficient to protect country's 220 million population

Published 11 Jan, 2021 01:24pm
  • Pakistan is still waiting for the United Nation’s Covax mechanism to receive around 45 million free vaccine doses that will cover country’s 20 percent population
  • Many states including Turkey, Columbia, Bangladesh, Malaysia and India have already struck deals with different COVID-19 vaccine manufacturing firms
  • The Pakistan government has allowed the private sector players to procure vaccine from anywhere in the world and get registered with DRAP
Sindh Health Secretary gets COVID-19 vaccine shot in clinical trials

Sindh Health Secretary gets COVID-19 vaccine shot in clinical trials

Published 31 Dec, 2020 03:04pm
  • “I have presented myself for the vaccine trial as secretary health,” says Dr Kazim Jatoi.
  • Several prominent public figures including Punjab Governor Chaudhry Sarwar and his wife have volunteered to be vaccinated in clinical trials of a Chinese vaccine being conducted in the country.
Loading...